옵션 체인은 다양한 행사가격과 만기일에 대한 Bancorp의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Bancorp에 대한 시장 심리를 평가합니다..

Bancorp (NASDAQ:TBBK) 주식, 옵션 체인

Bancorp

The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.

The Bancorp

The Bancorp Inc

WIIM

ABCB

ACNB

AMAL

AMTB

AROW

BANF

BANR

BCAL

BFST

BHLB

BHRB

BMRC

BOKF

BPOP

BRKL

BSRR

BSVN

BUSE

CARE

CASH

CATY

CBAN

CBNK

CBSH

CCBG

CCNE

CFFN

CHCO

CLBK

CNOB

COFS

CTBI

CUBI

CVBF

CZFS

DCOM

EBTC

EFSC

EGBN

EQBK

EWBC

FBIZ

FBMS

FBNC

FCBC

FCNCA

FFBC

FFIC

FFIN

FFWM

FIBK

FISI

FLIC

FMAO

FMBH

FMNB

FNLC

FRBA

FRME

FRST

FSBC

GABC

GBCI

GCBC

GNTY

GSBC

HAFC

HBCP

HBNC

HFBL

HFWA

HIFS

HMST

HOMB

HONE

HOPE

HTBI

HTBK

HTLF

Shares of banking-related companies are trading higher after Donald Trump won the US presidential election.

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.3% on Friday.
Shares of Capri Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) fell sharply in today's pre-market trading following reports that a judge has blocked the company's<a href="https://www.benzinga.com/m-a/24/10/41533172/capri-holdings-stock-drops-by-half-after-judge-blocks-tapestry-merger"> pending merger with Tapestry.</a>
Following an eight-day trial in which the U.S. Federal Trade Commission argued that a merger between Capri and Tapestry would remove competition from the U.S. handbag space, a U.S. judge has moved to block the pending merger, according to Reuters.
Capri shares tumbled 47.1% to $22.01 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares dipped 19.2% to $6.16 in today's pre-market trading after the company issued fourth-quarter revenue guidance below estimates and cut its FY24 revenue guidance,</li>
<li>The Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) shares declined 15.4% to $46.51 following downbeat quarterly results.</li>
<li>Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) dipped 8.1% to $5.55 in pre-market trading as the company announced the pricing of public offering of common stock.</li>
<li>Tevogen Bio Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares fell 7.8% to $2.36 in pre-market trading. Tevogen Bio recently announced its Artificial Intelligence effort, Tevogen AI, has joined Microsoft for Startups.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares fell 6.6% to $69.89 in pre-market trading following third-quarter results.</li>
<li>Sibanye Stillwater Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) declined 4.6% to $4.73 in pre-market trading after surging more than 12% on Thursday.</li>
<li>The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 4% to $289.80 in pre-market trading following third-quarter results.</li>
<li>Masimo Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) shares fell 4% to $135.23 in pre-market trading. Masimo will report third quarter financial results, after the closing bell on Tuesday, Nov. 5.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41528323/jim-cramer-says-hold-on-to-palantir-let-them-walk-it-up-warns-that-travere-therapeutics-is-losing-a">Jim Cramer Says &#8216;Hold On&#8217; To Palantir, &#8216;Let Them Walk It Up&#8217;; Warns That Travere Therapeutics Is Losing A &#8216;Ton Of Money&#8217;</a></li>
</ul>

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

COUR

CPRI

DXCM

JOBY

MASI

SBSW

TBBK

TVGN

Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Bancorp shares are trading lower after the company reported worse-than-expected Q3 financial results and issued FY24 EPS guidance below estimates.

Shares of Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41531479/deckers-outdoor-delivers-better-than-expected-q2-earnings-led-by-strength-in-hoka-ugg-brands">second-quarter financial results</a>.
Deckers reported second-quarter revenue of $1.31 billion, beating analyst estimates of $1.2 billion. The casual footwear and apparel company reported second-quarter earnings of $1.59, beating analyst estimates of $1.23 per share, according to Benzinga Pro.
Deckers Outdoor shares jumped 14% to $173.31 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Safe &amp; Green Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) rose 108.5% to $2.19 in pre-market trading after dipping around 20% on Thursday.</li>
<li>ARB IOT Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) gained 83.9% to $0.6070 in pre-market trading after falling over 10% on Thursday.</li>
<li>Jeffs&#8217; Brands Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) shares rose 60.6% to $0.44 in pre-market trading after the company announced it was granted a 180-day extension to regain Nasdaq compliance.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares surged 31% to $2.62 in pre-market trading. Faraday Future Partnered with UAE&#8217;s Royal Family for strategic expansion in Ras Al Khaimah.</li>
<li>Lyell Immunopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYEL#NASDAQ">LYEL</a>) shares jumped 24.7% to $1.37 in pre-market trading after the company announced it will acquire privately-owned clinical-stage biotechnology company ImmPACT Bio.</li>
<li>Inno Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INHD#NASDAQ">INHD</a>) rose 19.4% to $4.7200 in pre-market trading after declining 8% on Thursday.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) climbed 14.2% to $4.81 in pre-market trading after the company announced it dosed its first patients in its Phase 1 clinical study of CAR-NK cell therapy for relapsed B-Cell Non-Hodgkin Lymphoma.</li>
<li>Tapestry, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) gained 14.2% to $50.80 in pre-market trading as traders circulate a report alleging that a judge blocked the company&#8217;s proposed acquisition of Capri.</li>
<li>CleanCore Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#NASDAQ">ZONE</a>) shares rose 12.8% to $1.67 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Capri Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) shares dipped 47.1% to $22.01 in pre-market trading following reports that a judge has blocked the company's pending merger with Tapestry.</li>
<li>Monopar Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNPR#NASDAQ">MNPR</a>) shares fell 21.8% to $25.50 in pre-market trading. Monopar Therapeutics shares jumped 605% on Thursday after the company entered into an agreement with Alexion, AstraZeneca Rare Disease, for an exclusive worldwide license to ALXN-1840 for Wilson disease.</li>
<li>Hepion Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares fell 20.2% to $0.58 in pre-market trading after gaining 12% on Thursday.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) fell 19.2% to $6.16 in today's pre-market trading after the company issued fourth-quarter revenue guidance below estimates and cut its FY24 revenue guidance,</li>
<li>Quince Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>) fell 18.2% to $0.9723 in pre-market trading after jumping 37% on Thursday.</li>
<li>Alpha Technology Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) fell 17.3% to $7.97 in pre-market trading after jumping 52% on Thursday.</li>
<li>Bionomics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNOX#NASDAQ">BNOX</a>) declined 16.1% to $0.3020 in pre-market trading after jumping 24% on Thursday.</li>
<li>The Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) shares fell 15.4% to $46.51 following downbeat quarterly results.</li>
<li>Farmmi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAMI#NASDAQ">FAMI</a>) shares declined 12.9% to $0.4180 in pre-market trading. Farmmi shares jumped 24% on Thursday after the company announced it entered into a strategic cooperation agreement to further expand its logistic services business and potentially bring in an additional $10 million in annual orders</li>
<li>Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) fell 8.1% to $5.55 in pre-market trading as the company announced the pricing of public offering of common stock.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41528323/jim-cramer-says-hold-on-to-palantir-let-them-walk-it-up-warns-that-travere-therapeutics-is-losing-a">Jim Cramer Says &#8216;Hold On&#8217; To Palantir, &#8216;Let Them Walk It Up&#8217;; Warns That Travere Therapeutics Is Losing A &#8216;Ton Of Money&#8217;</a></li>
</ul>

ARBB

ATGL

BNOX

DECK

FAMI

FFIE

HEPA

IBRX

INHD

JFBR

LYEL

MNPR

QNCX

SGBX

ZONE

Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) affirms FY2024 GAAP EPS guidance from $4.35 to $4.35 vs $4.40 analyst estimate..

Guidance

Bancorp Affirms FY2024 GAAP EPS Guidance from $4.35 to $4.35 vs $4.40 Est

Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) is looking for FY2025 GAAP EPS of $5.25 vs $5.24 analyst estimate..

Bancorp Sees FY2025 GAAP EPS $5.25 vs $5.24 Est

Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) reported quarterly earnings of $1.04 per share which missed the analyst consensus estimate of $1.13 by 7.96 percent. The company reported quarterly sales of $93.732 million which missed the analyst consensus estimate of $99.310 million by 5.62 percent. This is a 5.46 percent increase over sales of $88.882 million the same period last year.

Earnings

Earnings Misses

Bancorp Q3 2024 GAAP EPS $1.04 Misses $1.13 Estimate, Sales $93.732M Miss $99.310M Estimate

Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) is preparing to release its quarterly earnings on Thursday, 2024-10-24. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Bancorp to report an earnings per share (EPS) of $1.13.
The market awaits Bancorp's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.00, leading to a 1.44% increase in the share price on the subsequent day.
Here's a look at Bancorp's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
<td>0.93</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
<td>0.92</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-8.0%</td>
<td>8.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729710130_0.png" alt="eps graph" />
<h3>Tracking Bancorp's Stock Performance</h3>
Shares of Bancorp were trading at $55.88 as of October 22. Over the last 52-week period, shares are up 65.77%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/TBBK/earnings">To track all earnings releases for Bancorp visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look Ahead: Bancorp's Earnings Forecast

BBVA

Shares of banking companies are trading lower in sympathy with overall market weakness. Investors may be assessing a recent report suggesting that Iran could be preparing to attack Israel, which could create shocks to the global economy.

ACRE

ALLY

ARES

ATCH

COHN

CRBG

FUTU

HIPO

HOOD

HSBC

HTGC

IBKR

JFIN

Janus Henderson Group plc Ordinary Shares

KSPI

LPLA

MOGO

MORN

NCPL

NDAQ

NRDS

NTRS

PRAA

RILY

SHF Holdings, Inc. - Class A Common Stock

SHFS

SNEX

SPGI

STEP

TROW

VCTR

VOYA

Shares of companies within the broader financial sector are trading lower amid overall weakness following concerns about recently issued US economic data.

Keefe, Bruyette &amp; Woods analyst Timothy Switzer reiterates Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) with a Outperform and raises the price target from $46 to $55.

Price Target

Reiteration

Analyst Ratings

Keefe, Bruyette & Woods Reiterates Outperform on Bancorp, Raises Price Target to $55

Piper Sandler analyst Frank Schiraldi maintains Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) with a Overweight and raises the price target from $55 to $60.

Piper Sandler Maintains Overweight on Bancorp, Raises Price Target to $60

The Bancorp Raises 2024 EPS Guidance From $4.25 To $4.35 vs $4.46 Est.

Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) reported quarterly earnings of $1.07 per share which met the analyst consensus estimate. This is a 20.22 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $93.80 million which missed the analyst consensus estimate of $96.41 million by 2.71 percent. This is a 7.57 percent increase over sales of $87.19 million the same period last year.

Bancorp Q2 Adj $1.07, Inline, Sales $93.80M Miss $96.41M Estimate

Bancorp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NYSE">TBBK</a>) short percent of float has risen 4.16% since its last report. The company recently reported that it has 6.40 million shares sold short, which is 15.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.53 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Bancorp Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721755817_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Bancorp has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Bancorp's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Bancorp's peer group average for short interest as a percentage of float is 4.45%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Bancorp?

Bank First Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfc#NASDAQ">BFC</a>) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.42 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 9.09%. A quarter ago, it was expected that this company would post earnings of $1.49 per share when it actually produced earnings of $1.51, delivering a surprise of 1.34%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Bank First Corporation, which belongs to the Zacks Banks - Northeast industry, posted revenues of $38.88 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 0.48%. This compares to year-ago revenues of $38.34 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Bank First Corporation shares have added about 1.5% since the beginning of the year versus the S&amp;P 500&#39;s gain of 18.1%.
What&#39;s Next for Bank First Corporation?
While Bank First Corporation has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Bank First Corporation: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.49 on $39.4 million in revenues for the coming quarter and $5.86 on $154.6 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Northeast is currently in the bottom 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
The Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tbbk#NASDAQ">TBBK</a>), another stock in the same industry, has yet to report results for the quarter ended June 2024. The results are expected to be released on July 25.
This holding company for The Bancorp Bank is expected to post quarterly earnings of $1.10 per share in its upcoming report, which represents a year-over-year change of +23.6%. The consensus EPS estimate for the quarter has been revised 0.9% higher over the last 30 days to the current level.
The Bancorp&#39;s revenues are expected to be $127.45 million, up 9.4% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2302942/bank-first-corporation-bfc-tops-q2-earnings-and-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2302942">To read this article on Zacks.com click here.</a>

Earnings Beats

Small Cap

Bank First Corporation Tops Q2 Earnings and Revenue Estimates

HBAN

MBWM

PPBI

Shares of banking stocks are trading higher amid sympathy with Bank of America after the company reported better-than-expected Q2 financial results.

COLB

IBOC

INDB

OVBC

SFBS

Shares of several banks are trading higher amid continued volatility following earning reports from several companies within the sector reported last last week.

Piper Sandler analyst Frank Schiraldi reiterates Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) with a Overweight and maintains $55 price target.

Piper Sandler Reiterates Overweight on Bancorp, Maintains $55 Price Target

Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) reported quarterly earnings of $1.06 per share which met the analyst consensus estimate. This is a 20.45 percent increase over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $94.418 million which missed the analyst consensus estimate of $116.507 million by 18.96 percent. This is a 10.02 percent increase over sales of $85.816 million the same period last year.

Bancorp Q1 2024 GAAP EPS $1.06, Inline, Sales $94.418M Miss $116.507M Estimate

Bancorp (TBBK) has shared an update. The Bancorp, Inc. announced the appointment of Todd J. Brockman to its Board of Directors, effective October 1...

Bancorp Appoints FinTech Expert Todd Brockman to Board

Simmons First National: A Big Step Back After A Solid Run (Rating Downgrade)

Comments

Bancorp

Bancorp (TBBK) 옵션

Bancorp (NASDAQ:TBBK) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌